How should sudden painless peripheral vision loss in one eye be evaluated and managed?

Sudden Painless Peripheral Vision Loss in One Eye

Suspect branch retinal artery occlusion (BRAO) and immediately evaluate for stroke risk, as up to 25% of patients with retinal artery occlusions will have a subsequent stroke. 1

Immediate Evaluation

This presentation requires urgent ophthalmologic evaluation and stroke workup, as retinal artery occlusions are now recognized as a form of acute ischemic stroke 2. The peripheral location suggests BRAO rather than central retinal artery occlusion (CRAO).

Critical History Elements

Obtain these specific details immediately 1:

• Exact duration of vision loss (minutes, hours, days)
• Giant cell arteritis (GCA) symptoms if patient >50 years old:
  • New headache, scalp tenderness, jaw claudication
  • Temporal artery tenderness, malaise, fever
  • Proximal muscle/joint pain (polymyalgia rheumatica)
• Vascular risk factors: hypertension, diabetes, hyperlipidemia, smoking, cardiovascular disease
• Recent trauma to neck or face (carotid dissection)
• Medications including cocaine use
• Preceding transient visual symptoms (amaurosis fugax)

Essential Physical Examination

Perform these specific tests 1:

• Visual acuity in both eyes
• Relative afferent pupillary defect (RAPD) assessment
• Dilated fundoscopy with indirect ophthalmoscopy:
  • Look for retinal emboli (Hollenhorst plaques)
  • Cotton-wool spots
  • Retinal hemorrhages
  • "Boxcarring" of blood in vessels
  • Optic disc neovascularization
• Intraocular pressure measurement
• Slit-lamp examination for neovascularization of iris (check before dilation)

Urgent Management Algorithm

Step 1: Rule Out GCA (Age >50)

If any GCA symptoms present 3:

• Immediately start high-dose corticosteroids (1 mg/kg prednisone or equivalent) before any testing
• Order ESR, CRP, and platelet count (expect elevations)
• Arrange temporal artery biopsy within 1-2 weeks
• Do not delay steroids waiting for biopsy—this prevents vision loss in the other eye

Step 2: Stroke Evaluation

Transfer to stroke center for comprehensive workup 2. Do not delay transfer for ancillary ophthalmologic testing.

The workup must identify stroke mechanism 2:

• Carotid imaging (ultrasound, CTA, or MRA): 37-40% have ≥70% ipsilateral carotid stenosis
• Cardiac evaluation: echocardiogram, telemetry for embolic sources
• Vascular risk factor assessment: lipid panel, HbA1c, blood pressure monitoring

Step 3: Ophthalmologic Documentation

These tests document extent but should not delay stroke evaluation 1:

• Optical coherence tomography (OCT): Shows inner retinal thickening acutely, thinning chronically
• Fluorescein angiography: Demonstrates arterial flow delays and extent of ischemia
• Fundus photography: Documents emboli characteristics and vascular changes

Critical Pitfalls to Avoid

1. Missing GCA: Always ask about systemic symptoms in patients >50. The window to prevent bilateral blindness is narrow.

2. Delaying stroke workup: Retinal artery occlusion carries the same stroke risk as cerebral ischemic events. The 25% stroke risk demands immediate vascular imaging 1.

3. Focusing only on the eye: This is a systemic vascular emergency. Up to 67% have cardiovascular risk factors requiring secondary prevention 2.

4. Waiting for ophthalmology before starting GCA treatment: If GCA is suspected clinically, start steroids immediately—biopsy can be done up to 2 weeks later without affecting diagnostic yield.

Secondary Prevention

After acute evaluation 2:

• Antiplatelet therapy (aspirin or clopidogrel)
• Statin therapy for lipid management
• Blood pressure control
• Carotid revascularization if ≥70% stenosis identified
• Cardiac intervention if embolic source found

Prognosis Context

Fewer than 20% of patients with retinal artery occlusions regain functional vision in the affected eye 2. The primary goals are preventing stroke and protecting the fellow eye, not restoring vision in the affected eye.